Advancements in Field of Multiple Sclerosis

Article

Joan Ohayon, registered nurse practitioner, discusses the advancements of research and treatment options in MS.

Joan Ohayon, registered nurse practitioner, National Institute of Neurological Disorders and Stroke, discusses the advancements of treating multiple sclerosis and clinical trials evaluating new treatments. Ohayon said that after the first approved MS treatment in 1993, there have been FDA six medications approved by the FDA.

Source:

Healthline

Related Videos
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
Kaitlin Mayne, MBChB | Credit X.com
Mona Shahriari, MD | Credit Central Connecticut Dermatology
Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care | Image Credit: Johns Hopkins University
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
© 2024 MJH Life Sciences

All rights reserved.